Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation

With post-transplantation cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis, nonmyeloablative HLA-haploidentical (NMA haplo) and HLA-matched blood or marrow transplantation (BMT) have comparable outcomes. Early discontinuation of immunosuppression may reduce the risk of relapse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Kasamon, Yvette L., Fuchs, Ephraim J., Zahurak, Marianna, Rosner, Gary L., Symons, Heather J., Gladstone, Douglas E., Huff, Carol Ann, Swinnen, Lode J., Brodsky, Robert A., Matsui, William H., Borrello, Ivan, Shanbhag, Satish, Cooke, Kenneth R., Ambinder, Richard F., Luznik, Leo, Bolaños-Meade, Javier, Jones, Richard J.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5977987/
https://ncbi.nlm.nih.gov/pubmed/29353109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.01.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars